drug · small molecule
patient view →APREPITANT
Marketedupdated 2mo agoby $HOTH Hoth Therapeutics, Inc.🔗 ChEMBL
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 7 approved and 18 investigational indications.
targets
Substance-P receptor
all catalysts(1)
approval · 1
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that